Determinants of Medication Adherence in HIV-Infected Adults with Hypertension
HIV 感染成人高血压患者药物依从性的决定因素
基本信息
- 批准号:8070092
- 负责人:
- 金额:$ 25.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-24 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdherenceAdultAdverse effectsAffectAgeAnti-Retroviral AgentsAntihypertensive AgentsAttentionBeliefCardiovascular DiseasesCaringCause of DeathChronicChronic DiseaseComorbidityComplicationDevelopmentDiseaseElectronicsEthnic OriginFutureGoalsGrantHIVHIV InfectionsHIV SeropositivityHigh PrevalenceHispanicsHypertensionIndividualInformal Social ControlInterventionKidney FailureKnowledgeLifeMedicalMinority GroupsModelingMonitorMorbidity - disease rateNot Hispanic or LatinoNursesOutcomePatientsPatternPerceptionPersonsPharmaceutical PreparationsPlayPopulationPublic HealthRaceRegimenResearchRisk FactorsRoleSamplingSelf ManagementStagingStrokeTranslatingantiretroviral therapybasecardiovascular disorder riskcostdisorder controldisorder riskeffective interventionefficacy testingethnic minority populationhealth beliefhealth disparityhypertension treatmentillness perceptionsimprovedinner citymedication compliancemembermortalityracial and ethnicresearch and developmentsystolic hypertensiontheories
项目摘要
DESCRIPTION (provided by applicant): There is an urgent need for research on medication adherence in HIV-infected individuals that goes beyond ARV therapy and investigates determinants of adherence to medications for medical comorbidities. Due to the development of highly-effective antiretroviral (ARV) therapy, AIDS has been transformed from a fatal illness to a chronic one and mortality due to comorbid conditions has increased considerably among HIV-infected persons. As HIV-infected adults live longer lives, they are increasingly at risk for diseases of aging, including cardiovascular disease (CVD). HIV infection and ARV therapy have been associated with increased risks of CVD, and CVD now ranks as a major cause of death in this population. A major risk factor for CVD is hypertension (HTN), as well as stroke and renal failure (a common complication of HIV infection). Many patients do no achieve adequate disease control, despite the availability of effective medications for HIV and HTN. While medication adherence is a key aspect of chronic disease self-management, it has been well documented that approximately 50% of patients with chronic diseases do not adhere to their medication regimens, a pattern that translates into poor outcomes and increased medical costs. This study proposes to investigate adherence to antihypertensive medication in HIV-infected adults on ARVs with comorbid HTN, one of the most prevalent comorbid conditions in HIV-infected persons. Using Self- Regulation Theory as a framework, the focus will be on identifying potentially modifiable factors that could be the target of future nurse-led interventions to improve adherence, with specific attention for the role of race and ethnicity. The Specific Aims of this study are to: (1) Determine the relationship between disease-specific adherence factors (illness representation and beliefs about the necessity of medication and concerns about potential adverse effects) and adherence to antihypertensive and ARV medication in HIV-positive subjects with comorbid HTN; (2) Explore differences in HIV and HTN illness representation and medication beliefs among the three most prevalent racial/ethnic patient groups (blacks, Hispanics, non-Hispanic whites), controlling for stage of disease. The study will use electronic monitoring to prospectively assess adherence to one antihypertensive and one ARV medication over a 10-week period in an ethnically diverse sample of 200 inner- city HIV-positive subjects. This study will provide a model for integrating adherence to medications for comorbid medical conditions into nurse-led adherence interventions for HIV-infected persons. Study findings will serve as the basis for the development of research which will test the efficacy of a nurse-led adherence intervention targeting both adherence to ARVs and antihypertensives in HIV-infected persons with comorbid HTN. It will produce knowledge which can be used to effectively intervene to decrease the risk for cardiovascular disease among HIV-positive adults on highly-effective ARV therapy.
PUBLIC HEALTH RELEVANCE: Hypertension is one of the most prevalent comorbid conditions in persons with HIV-infection and cardiovascular disease now ranks as a major cause of death in this population. This study will investigate determinants of adherence to the treatment of hypertension in HIV-infected persons with the goal of leading to interventions to decrease the risk for cardiovascular disease among HIV- positive adults on highly-effective ARV therapy.
描述(由申请人提供):迫切需要对HIV感染者的药物依从性进行研究,超越ARV治疗,并调查医疗合并症药物依从性的决定因素。由于高效抗逆转录病毒疗法的发展,艾滋病已从一种致命疾病转变为一种慢性疾病,艾滋病毒感染者因合并症而死亡的人数大幅增加。随着艾滋病毒感染的成年人寿命延长,他们患老年疾病的风险越来越大,包括心血管疾病。HIV感染和抗逆转录病毒治疗与心血管疾病风险增加有关,心血管疾病现在已成为这一人群的主要死因。心血管疾病的一个主要危险因素是高血压(HTN),以及中风和肾衰竭(艾滋病毒感染的常见并发症)。尽管有有效的HIV和HTN药物,但许多患者没有得到充分的疾病控制。虽然药物依从性是慢性病自我管理的一个关键方面,但有充分的证据表明,大约50%的慢性病患者不遵守他们的药物治疗方案,这种模式转化为不良结果和增加的医疗成本。 本研究旨在调查接受抗逆转录病毒药物治疗的HIV感染成人中合并HTN(HIV感染者中最常见的合并症之一)的抗高血压药物依从性。使用自我调节理论作为框架,重点将是确定潜在的可修改的因素,这些因素可能是未来护士主导的干预措施的目标,以提高依从性,特别注意种族和民族的作用。本研究的具体目的是:(1)确定疾病特异性粘附因子之间的关系(疾病陈述和对药物治疗必要性的信念以及对潜在不良反应的担忧)以及对合并HTN的HIV阳性受试者的抗高血压和ARV药物治疗的依从性;(2)探索三个最流行的种族/民族患者群体在艾滋病毒和HTN疾病表现和药物信仰方面的差异(黑人,西班牙裔,非西班牙裔白人),控制疾病的阶段。该研究将使用电子监测,前瞻性评估200名内城HIV阳性受试者的种族多样性样本在10周内对一种抗高血压药物和一种ARV药物的依从性。这项研究将提供一个模型,将合并症的药物治疗依从性纳入护士主导的艾滋病毒感染者依从性干预措施。研究结果将作为基础的发展研究,这将测试的效果,护士主导的坚持干预,针对艾滋病毒感染者与共病HTN坚持抗逆转录病毒药物和抗高血压药物。它将产生可用于有效干预的知识,以降低接受高效抗逆转录病毒治疗的艾滋病毒阳性成年人患心血管疾病的风险。
公共卫生相关性:高血压是艾滋病毒感染者中最常见的共病之一,心血管疾病现已成为这一人群的主要死亡原因。本研究将调查HIV感染者坚持高血压治疗的决定因素,目的是采取干预措施,降低接受高效抗逆转录病毒治疗的HIV阳性成年人患心血管疾病的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY J WEISS其他文献
JEFFREY J WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY J WEISS', 18)}}的其他基金
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
提高 HIV/HCV 合并感染中 HCV 治疗采用率和依从性的干预措施
- 批准号:
8602736 - 财政年份:2013
- 资助金额:
$ 25.43万 - 项目类别:
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
提高 HIV/HCV 合并感染中 HCV 治疗采用率和依从性的干预措施
- 批准号:
8897449 - 财政年份:2013
- 资助金额:
$ 25.43万 - 项目类别:
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
提高 HIV/HCV 合并感染中 HCV 治疗采用率和依从性的干预措施
- 批准号:
8714061 - 财政年份:2013
- 资助金额:
$ 25.43万 - 项目类别:
Determinants of Medication Adherence in HIV-Infected Adults with Hypertension
HIV 感染成人高血压患者药物依从性的决定因素
- 批准号:
8147820 - 财政年份:2010
- 资助金额:
$ 25.43万 - 项目类别:
Adherence to HCV Treatment in HCV and HCV/HIV Patients
HCV 和 HCV/HIV 患者对 HCV 治疗的依从性
- 批准号:
7189933 - 财政年份:2005
- 资助金额:
$ 25.43万 - 项目类别:
Adherence to HCV Treatment in HCV and HCV/HIV Patients
HCV 和 HCV/HIV 患者对 HCV 治疗的依从性
- 批准号:
6891756 - 财政年份:2005
- 资助金额:
$ 25.43万 - 项目类别:
Adherence to HCV Treatment in HCV and HCV/HIV Patients
HCV 和 HCV/HIV 患者对 HCV 治疗的依从性
- 批准号:
7355530 - 财政年份:2005
- 资助金额:
$ 25.43万 - 项目类别:
Adherence to HCV Treatment in HCV and HCV/HIV Patients
HCV 和 HCV/HIV 患者对 HCV 治疗的依从性
- 批准号:
7567550 - 财政年份:2005
- 资助金额:
$ 25.43万 - 项目类别:
Adherence to HCV Treatment in HCV and HCV/HIV Patients
HCV 和 HCV/HIV 患者对 HCV 治疗的依从性
- 批准号:
7026482 - 财政年份:2005
- 资助金额:
$ 25.43万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 25.43万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 25.43万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 25.43万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 25.43万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 25.43万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 25.43万 - 项目类别: